Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Pliant Therapeutics
PLRX
$64.4M
| $8.21M | ﹤0.01% |
281,856
-276
| -0.1% | -$8.59K |
|
2602
Banco Bradesco
BBD
$39.4B
| $8.17M | ﹤0.01% |
1,752,110
+8,294
| +0.5% | +$36.1K |
|
2603
Mercantile Bank Corp
MBWM
$1.05B
| $8.17M | ﹤0.01% |
270,510
+2,655
| +1% | +$84.6K |
|
|
TRIL
2604
DELISTED
Trillium Therapeutics Inc.
TRIL
| $8.15M | ﹤0.01% |
839,889
+766,327
| +1,042% | +$7.21M |
|
2605
First Community Bankshares
FCBC
$904M
| $8.14M | ﹤0.01% |
272,695
+1,432
| +0.5% | +$43.3K |
|
2606
Independent Bank Corp
IBCP
$793M
| $8.13M | ﹤0.01% |
374,455
+889
| +0.2% | +$20.5K |
|
2607
Hackett Group
HCKT
$285M
| $8.12M | ﹤0.01% |
450,835
+2,960
| +0.7% | +$51.5K |
|
|
GNOG
2608
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $8.12M | ﹤0.01% |
636,432
+307,409
| +93% | +$4.17M |
|
|
WCN
2609
Waste Connections
WCN
$42.3B
| $8.1M | ﹤0.01% |
69,153
+7,418
| +12% | +$883K |
|
2610
ATN International
ATNI
$379M
| $8.1M | ﹤0.01% |
178,055
+868
| +0.5% | +$41.4K |
|
2611
IDEAYA Biosciences
IDYA
$3.41B
| $8.1M | ﹤0.01% |
385,888
+107,795
| +39% | +$2.21M |
|
|
NAGE
2612
Niagen Bioscience
NAGE
$281M
| $8.09M | ﹤0.01% |
820,732
+84,995
| +12% | +$741K |
|
|
KALV
2613
DELISTED
KalVista Pharmaceuticals
KALV
| $8.08M | ﹤0.01% |
337,277
+10,010
| +3% | +$262K |
|
2614
Standard BioTools
LAB
$339M
| $8.08M | ﹤0.01% |
1,311,872
+42,952
| +3% | +$230K |
|
|
TCRR
2615
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $8.07M | ﹤0.01% |
491,836
+36,526
| +8% | +$738K |
|
|
PARAA
2616
DELISTED
Paramount Global Class A
PARAA
| $8.06M | ﹤0.01% |
166,468
+30,320
| +22% | +$1.38M |
|
2617
Eos Energy Enterprises
EOSE
$1.36B
| $8.05M | ﹤0.01% |
448,373
+141,777
| +46% | +$2.29M |
|
|
FLIC
2618
DELISTED
First of Long Island Corp
FLIC
| $8.05M | ﹤0.01% |
379,136
-991
| -0.3% | -$21.7K |
|
2619
BioXcel Therapeutics
BTAI
$26.2M
| $8.04M | ﹤0.01% |
17,301
+1,511
| +10% | +$824K |
|
|
GATO
2620
DELISTED
Gatos Silver, Inc.
GATO
| $8.03M | ﹤0.01% |
459,077
+102,429
| +29% | +$1.44M |
|
2621
American Vanguard Corp
AVD
$70.4M
| $8.02M | ﹤0.01% |
457,838
+3,336
| +0.7% | +$63.3K |
|
2622
REX American Resources
REX
$1.42B
| $8.02M | ﹤0.01% |
533,304
+9,720
| +2% | +$141K |
|
2623
Republic Bancorp
RBCAA
$1.95B
| $7.98M | ﹤0.01% |
172,920
+5,229
| +3% | +$239K |
|
|
KC
2624
Kingsoft Cloud Holdings
KC
$3.56B
| $7.97M | ﹤0.01% |
236,502
+13,394
| +6% | +$536K |
|
|
PRVB
2625
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $7.93M | ﹤0.01% |
940,604
+74,854
| +9% | +$604K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.